Multiple Sclerosis News Today Forums › Forums › Trials and Research › #ECTRIMS2019 – Mayzent’s Benefits for MS Patients a ‘Key Question,’ Says EXPAND’s Principal Investigator

  • Trials and Research

    #ECTRIMS2019 – Mayzent’s Benefits for MS Patients a ‘Key Question,’ Says EXPAND’s Principal Investigator

    Posted by ms-news-today-moderator on October 4, 2019 at 6:24 am

    Ludwig Kappos, principal investigator of the EXPAND study, discusses how new analyses are answering the question of how Mayzent benefits patients. Read the full story here.

    What do you think of this study and its findings?

    replied 4 years, 6 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .